FDA NDC Directory · JSON-LD · Markdown

Columvi

NDC 50242-127 · HUMAN PRESCRIPTION DRUG · CONCENTRATE

Generic nameGlofitamab
Labeler / ManufacturerGenentech, Inc.
Marketing categoryBiologic License Application · App BLA761309
Dosage form / routeCONCENTRATE · INTRAVENOUS
Active ingredientsGLOFITAMAB (10 mg/10mL)
Marketing started20230615
Package count1

External sources

Source: openFDA. Public-domain (CC0).